Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved XIFYRMtm (meloxicam injection), an IV non-steroidal anti-inflammatory drug (NSAID) that ...

The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

For those who need frequent blood draws or IV (intravenous) treatments, a port can make it easier to access a vein and reduce the number of needle pricks you receive. Most of us are familiar with ...